Biologics APIs

Oct 12, 2018
By Pharmaceutical Technology Editors
A new investigational vaccine, LASSARAB, shows promise for use against Lassa fever and rabies.
Sep 28, 2018
By Pharmaceutical Technology Editors
CPhI releases the bio trends portion of its annual report, which predicts an increase in bioconjucation expertise and biopharma productivity over the next five years.
Sep 25, 2018
By Pharmaceutical Technology Editors
Cell-line quality has a significant impact on biologic drug quality; learn more about this and other upstream challenges at the new bioLIVE launching this year adjacent to CPhI Worldwide 2018.
Sep 20, 2018
By Pharmaceutical Technology Editors
The CHF 400-million (US$416-million) investment in Lonza's biopark in Visp, Switzerland, will expand Ibex Solutions with two new offerings, drug substance development and drug substance and drug product manufacturing.
Sep 13, 2018
By Pharmaceutical Technology Editors
The collaboration will focus on developing manufacturing solutions for biosimilars.
Sep 10, 2018
By Pharmaceutical Technology Editors
The collaboration will explore the potential of Dyadic’s gene-expression platform to produce multiple biologic vaccines and drugs.
Sep 01, 2018
Pharmaceutical Technology
Immobilizing the antibodies on a solid-phase support, such as a resin, and carrying out the conjugation of the payload-linker while the antibodies are bound to that support will prevent aggregation at its source.
Aug 14, 2018
By Pharmaceutical Technology Editors
Drug product approval from FDA follows previous approvals from European and Japanese authorities.
Aug 13, 2018
By Pharmaceutical Technology Editors
The new drug, Onpattro (patisiran), by Alnylam Pharmaceuticals, is in a new class of drugs called small interfering ribonucleic acid (siRNA) treatment.
Aug 06, 2018
By Pharmaceutical Technology Editors
The companies will collaborate on the discovery, development, and commercialization of cell therapies for cancer.
native1_300x100
lorem ipsum